Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
American Renal Associates Holdings, Inc. stock logo
ARA
American Renal Associates
$11.52
$11.50
$5.57
$11.98
$397.94M1.11106,940 shs9,831 shs
Azenta, Inc. stock logo
AZTA
Azenta
$32.34
-1.1%
$30.92
$23.91
$60.60
$1.50B1.64540,877 shs496,951 shs
CONMED Corporation stock logo
CNMD
CONMED
$52.25
+2.2%
$53.02
$46.00
$78.19
$1.58B1.17487,359 shs626,071 shs
Enovis Corporation stock logo
ENOV
Enovis
$25.74
-4.0%
$31.04
$25.70
$49.83
$1.53B1.71.51 million shs1.34 million shs
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
American Renal Associates Holdings, Inc. stock logo
ARA
American Renal Associates
0.00%0.00%0.00%0.00%0.00%
Azenta, Inc. stock logo
AZTA
Azenta
-1.10%-6.07%-1.55%+19.96%-48.08%
CONMED Corporation stock logo
CNMD
CONMED
+2.49%+2.60%-3.63%-9.16%-24.38%
Enovis Corporation stock logo
ENOV
Enovis
-3.69%-6.51%-22.97%-26.93%-45.97%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
American Renal Associates Holdings, Inc. stock logo
ARA
American Renal Associates
N/AN/AN/AN/AN/AN/AN/AN/A
Azenta, Inc. stock logo
AZTA
Azenta
2.6632 of 5 stars
2.12.00.80.02.12.52.5
CONMED Corporation stock logo
CNMD
CONMED
4.4096 of 5 stars
2.13.02.54.31.90.83.1
Enovis Corporation stock logo
ENOV
Enovis
3.1915 of 5 stars
3.43.00.00.02.21.71.9
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
American Renal Associates Holdings, Inc. stock logo
ARA
American Renal Associates
0.00
N/AN/AN/A
Azenta, Inc. stock logo
AZTA
Azenta
2.25
Hold$36.6713.38% Upside
CONMED Corporation stock logo
CNMD
CONMED
2.20
Hold$59.8014.45% Upside
Enovis Corporation stock logo
ENOV
Enovis
2.80
Moderate Buy$55.60116.01% Upside

Current Analyst Ratings Breakdown

Latest ARA, AZTA, ENOV, and CNMD Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
7/31/2025
CONMED Corporation stock logo
CNMD
CONMED
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$80.00 ➝ $68.00
7/22/2025
Azenta, Inc. stock logo
AZTA
Azenta
Stephens
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageEqual Weight$35.00
7/8/2025
Azenta, Inc. stock logo
AZTA
Azenta
Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetIn-Line ➝ In-Line$29.00 ➝ $35.00
7/8/2025
Enovis Corporation stock logo
ENOV
Enovis
Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform ➝ Outperform$48.00 ➝ $46.00
6/12/2025
CONMED Corporation stock logo
CNMD
CONMED
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeBuy ➝ Hold$61.00
5/14/2025
Enovis Corporation stock logo
ENOV
Enovis
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$75.00 ➝ $70.00
5/9/2025
Enovis Corporation stock logo
ENOV
Enovis
JMP Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetMarket Outperform ➝ Market Outperform$62.00 ➝ $55.00
5/9/2025
Enovis Corporation stock logo
ENOV
Enovis
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$64.00 ➝ $57.00
5/7/2025
Azenta, Inc. stock logo
AZTA
Azenta
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$59.00 ➝ $40.00
(Data available from 8/2/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
American Renal Associates Holdings, Inc. stock logo
ARA
American Renal Associates
$822.52M0.48$1.69 per share6.80$2.59 per share4.45
Azenta, Inc. stock logo
AZTA
Azenta
$669.17M2.21$4.50 per share7.19$36.16 per share0.89
CONMED Corporation stock logo
CNMD
CONMED
$1.31B1.24$6.86 per share7.62$31.16 per share1.68
Enovis Corporation stock logo
ENOV
Enovis
$2.11B0.70$18.52 per share1.39$45.10 per share0.57
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
American Renal Associates Holdings, Inc. stock logo
ARA
American Renal Associates
-$13.79M$0.26N/AN/AN/A-2.04%-3.56%-0.24%N/A
Azenta, Inc. stock logo
AZTA
Azenta
-$164.17M-$1.39N/A35.15N/A-10.31%1.30%1.10%8/5/2025 (Estimated)
CONMED Corporation stock logo
CNMD
CONMED
$132.42M$3.5314.8010.311.308.31%14.60%6.06%N/A
Enovis Corporation stock logo
ENOV
Enovis
-$825.49M-$13.95N/A8.07N/A-37.65%5.99%3.44%8/7/2025 (Estimated)

Latest ARA, AZTA, ENOV, and CNMD Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/7/2025Q2 2025
Enovis Corporation stock logo
ENOV
Enovis
$0.74N/AN/AN/A$555.80 millionN/A
8/5/2025Q3 2025
Azenta, Inc. stock logo
AZTA
Azenta
$0.13N/AN/AN/A$149.64 millionN/A
7/30/2025Q2 2025
CONMED Corporation stock logo
CNMD
CONMED
$1.13$1.15+$0.02$0.69$338.42 million$342.35 million
5/8/2025Q1 2025
Enovis Corporation stock logo
ENOV
Enovis
$0.74$0.81+$0.07-$0.98$558.80 million$558.83 million
5/7/2025Q2 2025
Azenta, Inc. stock logo
AZTA
Azenta
$0.09$0.05-$0.04-$0.89$140.87 millionN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
American Renal Associates Holdings, Inc. stock logo
ARA
American Renal Associates
N/AN/AN/AN/AN/A
Azenta, Inc. stock logo
AZTA
Azenta
$0.100.31%N/AN/A N/A
CONMED Corporation stock logo
CNMD
CONMED
$0.801.53%N/A22.66%N/A
Enovis Corporation stock logo
ENOV
Enovis
N/AN/AN/AN/AN/A

Latest ARA, AZTA, ENOV, and CNMD Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
5/21/2025
CONMED Corporation stock logo
CNMD
CONMED
quarterly$0.201.34%6/13/20256/13/20257/3/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
American Renal Associates Holdings, Inc. stock logo
ARA
American Renal Associates
7.54
1.05
1.02
Azenta, Inc. stock logo
AZTA
Azenta
N/A
3.22
2.84
CONMED Corporation stock logo
CNMD
CONMED
0.91
2.26
1.00
Enovis Corporation stock logo
ENOV
Enovis
0.52
2.55
1.32

Institutional Ownership

CompanyInstitutional Ownership
American Renal Associates Holdings, Inc. stock logo
ARA
American Renal Associates
78.42%
Azenta, Inc. stock logo
AZTA
Azenta
99.08%
CONMED Corporation stock logo
CNMD
CONMED
N/A
Enovis Corporation stock logo
ENOV
Enovis
98.45%

Insider Ownership

CompanyInsider Ownership
American Renal Associates Holdings, Inc. stock logo
ARA
American Renal Associates
9.50%
Azenta, Inc. stock logo
AZTA
Azenta
10.62%
CONMED Corporation stock logo
CNMD
CONMED
3.10%
Enovis Corporation stock logo
ENOV
Enovis
2.70%
CompanyEmployeesShares OutstandingFree FloatOptionable
American Renal Associates Holdings, Inc. stock logo
ARA
American Renal Associates
4,97734.54 millionN/AOptionable
Azenta, Inc. stock logo
AZTA
Azenta
3,30045.78 million40.92 millionOptionable
CONMED Corporation stock logo
CNMD
CONMED
3,90030.94 million29.98 millionOptionable
Enovis Corporation stock logo
ENOV
Enovis
7,36757.12 million55.58 millionOptionable

Recent News About These Companies

Enovis (ENOV) Expected to Announce Quarterly Earnings on Thursday
Enovis (ENOV) Projected to Post Earnings on Thursday
Enovis (ENOV) Stock Trades Up, Here Is Why
Enovis (NYSE:ENOV) Trading Down 4.3% - What's Next?

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
American Renal Associates stock logo

American Renal Associates NYSE:ARA

American Renal Associates Holdings, Inc. operates as a dialysis services provider in the United States. It operates dialysis clinics focusing on joint venture partnerships with physicians. The company offers kidney dialysis services to patients suffering from chronic kidney failure or end stage renal disease. As of December 31, 2019, it operated 246 dialysis clinics in partnership with 400 nephrologist partners treating approximately 17,300 patients in 27 states and the District of Columbia. The company was founded in 1999 and is headquartered in Beverly, Massachusetts.

Azenta stock logo

Azenta NASDAQ:AZTA

$32.34 -0.36 (-1.10%)
Closing price 08/1/2025 04:00 PM Eastern
Extended Trading
$32.34 -0.01 (-0.02%)
As of 08/1/2025 07:01 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Azenta, Inc. provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services. The Life Sciences Products segment offers automated cold storage solutions, consumables and instruments, controlled rate thawing devices, and temperature-controlled storage and transportation solutions. This segment also provides sample management solutions, such as consumable vials and tubes, polymerase chain reaction, plates, instruments for supporting workflows, and informatics. The Life Sciences Services segment provides genomic services, that includes gene sequencing and gene synthesis services; and sample repository solutions, such as on-site and off-site sample storage, cold chain logistics, sample transport and collection relocation, bio-processing solutions, disaster recovery and business continuity, and biospecimen procurement services, as well as project management and consulting services for genomic analysis and the management and care of biological samples used in pharmaceutical, biotech, healthcare, clinical, and academic research, and development sectors. It serves a range of life science customers, including pharmaceutical companies, biotechnology companies, biorepositories, and research institutes. The company was formerly known as Brooks Automation, Inc. and changed its name to Azenta, Inc. in December 2021. Azenta, Inc. was founded in 1978 and is headquartered in Burlington, Massachusetts.

CONMED stock logo

CONMED NYSE:CNMD

$52.25 +1.10 (+2.15%)
Closing price 08/1/2025 03:59 PM Eastern
Extended Trading
$52.28 +0.03 (+0.07%)
As of 08/1/2025 04:41 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for surgical procedures worldwide. The company offers orthopedic surgery products, including BioBrace, TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and Agro Knotless Suture Anchors, which provide clinical solutions to orthopedic surgeons for the augmentation and repair of soft tissue injuries, as well as provides supporting products that enable surgeons to perform minimally invasive sports medicine surgeries. It markets orthopedic surgery products under the Hall, CONMED Linvatec, Concept, and Shutt brands. The company also provides battery-powered and autoclavable bone power tool systems for use in orthopedic, arthroscopic, oral/maxillofacial, podiatric, spinal, and cardiothoracic surgeries under Hall surgical brand name. In addition, it offers general surgery products, including clinical insufflation systems under AirSeal brand; smoke removal devices under Buffalo Filter brand; endomechanical products, such as tissue retrieval bags, trocars, suction irrigation devices, graspers, scissors, and dissectors used in minimally invasive surgeries; and electrosurgical solution comprising monopolar and bipolar generators, argon beam coagulation generators, handpieces, smoke management systems and other accessories. Further, the company provides endoscopic technologies, including therapeutic and diagnostic products for use in gastroenterology procedures, and products for the treatment of diseases of the dilatation, hemostasis, biliary, structure management, and infection prevention and patient monitoring, including ECG and EEG electrodes, and cardiac defibrillation pads. It markets its products directly to hospitals, surgery centers, and other healthcare institutions, as well as through medical specialty distributors. CONMED Corporation was incorporated in 1970 and is headquartered in Largo, Florida.

Enovis stock logo

Enovis NYSE:ENOV

$25.74 -1.06 (-3.96%)
Closing price 08/1/2025 03:59 PM Eastern
Extended Trading
$25.74 0.00 (0.00%)
As of 08/1/2025 04:38 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Enovis Corporation operates as a medical technology company focus on developing clinically differentiated solutions worldwide. It also manufactures and distributes medical devices which are used for reconstructive surgery, rehabilitation, pain management, and physical therapy. The company operates through Prevention and Recovery, and Reconstructive segments. Its Prevention and Recovery segment offers orthopedic solutions and recovery sciences including rigid and soft orthopedic bracing, hot and cold therapy, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators management, and physical therapy products which are used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals. The company's Reconstructive segment operates surgical implant business, which includes a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger, as well as surgical productivity tools. The company distributes its products through independent distributors and directly under the ESAB and DJO brands. Enovis Corporation was formerly known as Colfax Corporation. The company was founded in 1995 and is headquartered in Wilmington, Delaware.